Lantheus Holdings, Inc. income statement

In fiscal 2025, Lantheus Holdings, Inc. reported revenue of $1.54bn, up 0.5% on the year before, operating income of $311m (a 20.2% margin) and net income of $234m, or $3.41 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Lantheus Holdings, Inc.: income statement, annual
Fiscal year	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	284	302	293	302	331	343	347	339	425	935	1,296	1,534	1,542	1,556
Cost of revenue	—	—	—	164	169	168	173	201	238	353	587	546	600	620
Gross profit	77	126	136	138	162	175	175	139	188	582	710	988	942	936
Research and development	30	14	14	12	18	17	20	33	45	312	78	168	177	173
Selling and marketing	35	35	35	37	42	43	42	41	68	100	142	178	179	231
General and administrative	33	37	44	39	50	50	61	69	150	134	125	194	275	230
Operating income	−19	39	43	57	52	64	52	−4	−61	36	365	457	311	302
Interest expense	43	42	39	27	18	17	14	9	8	7	20	20	20	20
Income before tax	−61	−2	−12	28	40	50	29	−11	−75	27	411	431	314	363
Income tax	1	1	3	2	−84	9	−3	2	−4	−1	84	119	80	88
Net income	−62	−4	−15	27	123	41	32	−13	−71	28	327	312	234	275
Diluted EPS	−$3.42	−$0.20	−$0.60	$0.82	$3.17	$1.03	$0.79	−$0.25	−$1.06	$0.40	$4.65	$4.36	$3.41	$4.15
Diluted shares (average)	18,032m	18m	24m	33m	39m	40m	40m	54m	67m	71m	70m	72m	68m	66m
EBITDA	7	58	62	75	71	78	65	20	−19	84	425	522	381	391

US$ millions unless shown otherwise. Fiscal quarters.

Lantheus Holdings, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	379	391	373	378	384	407	377	388
Cost of revenue	137	143	135	137	162	166	146	146
Gross profit	242	249	238	241	222	241	231	242
Research and development	24	35	36	45	48	47	39	38
Selling and marketing	44	44	43	41	49	46	53	83
General and administrative	41	58	57	67	82	70	58	21
Operating income	134	114	102	88	44	77	81	100
Interest expense	5	5	5	5	5	5	5	5
Income before tax	176	−1	97	105	42	70	156	94
Income tax	45	11	24	26	15	16	38	19
Net income	131	−12	73	79	28	54	118	75
Diluted EPS	$1.79	−$0.19	$1.02	$1.12	$0.41	$0.81	$1.80	$1.11
EBITDA	151	131	116	101	64	100	104	123

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: LNTH vs PAHC INDV vs LNTH LNTH vs TRLV

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Lantheus Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Lantheus Holdings, Inc.